We’ve seen examples of Dr Saha’s excellent work here before.
He is super excited by the whole enterprise of tissue-engineered reconstruction describing this as avant-garde plastic surgery. Of relevance to PolyNovo’s push into India is that Saha works in Kolkata. Hopefully, he can be a KOL that Poly has connected with.
In this 2021 paper he forecast the market value of regenerative tissue engineering to grow from $7B in 2016 to $17B this year, and described it as a “hugely evolving market”: https://www.srinjoysaha.com/post/tissue-engineering-for-better-plastic-surgery
The Clinicians Speak, page-502
-
- There are more pages in this discussion • 552 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.56 |
Change
-0.050(1.92%) |
Mkt cap ! $1.768B | |||
| Open | High | Low | Value | Volume |
| $2.59 | $2.65 | $2.55 | $4.577M | 1.763M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 21966 | $2.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.57 | 1899 | 1 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| PNV (ASX) Chart |